Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Strata Critical Medical, Inc.SRTA · Entity 5512 | Chief Accounting Officer | September 08, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Strata Critical Medical, Inc.
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 177,154 |
Reported balance
After 2026-09-08 transaction · row 1
1 source rowRow 1 · 2026-09-08 · Tax withholding · Disposed 4,645 · Balance 177,154 F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2026 Filed Sep 10, 2026 20:27 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 4,645 | $5.31 | $24,664.95 |
DisclosureSEC source: 0001628280-26-061364 · wk-form4_1789072046.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,154 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 20:05 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 34,015 | $5.09 | $173,136.35 |
DisclosureSEC source: 0001628280-26-051809 · wk-form4_1785787536.xml · nonDerivative · entry 3 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,799 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 20:05 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 27,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-051809 · wk-form4_1785787536.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,814 F2 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025. Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 20:05 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 41,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-051809 · wk-form4_1785787536.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,394 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 4,655 | $5.87 | $27,324.85 |
DisclosureSEC source: 0001628280-26-042182 · wk-form4_1781121963.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,608 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 08, 2026 Filed Jun 18, 2026 20:10 UTC Amendment | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 4,655 | $5.87 | $27,324.85 |
DisclosureSEC source: 0001628280-26-044281 · wk-form4a_1781813421.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,608 F1 · kind: On June 10, 2026, the reporting person filed a Form 4 (the "Original Form") which inadvertently used the "S" code in Column 3 of Table I in connection with the disposal of certain shares of the Issuer's Class A common stock (the "Shares") on June 8, 2026. The Shares were in fact withheld by the Issuer to satisfy tax withholding obligations in connection a vesting event in a transaction approved in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Footnote 1 to the Original Form correctly described the transaction as "shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units." Accordingly, the reporting person is hereby amending the Original Form to correctly show the "F" code in Column 3 of Table I. The information set forth in the Original Form was correct in all other respects. F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 22, 2026 Filed May 26, 2026 20:49 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 40,575 | $5.91 | $239,798.25 |
DisclosureSEC source: 0001628280-26-038171 · wk-form4_1779828592.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,263 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.81 to $6.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:49 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 10,300 | $5.79 | $59,637.00 |
DisclosureSEC source: 0001628280-26-038171 · wk-form4_1779828592.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191,838 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:04 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 14,306 | $5.79 | $82,831.74 |
DisclosureSEC source: 0001628280-26-034586 · wk-form4_1778702684.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 202,138 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.79 to $5.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 21:46 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 40,960 | $4.92 | $201,523.20 |
DisclosureSEC source: 0001628280-26-027658 · wk-form4_1777326401.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,444 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:46 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 83,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-027658 · wk-form4_1777326401.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,404 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 21:29 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 2,433 | $4.54 | $11,045.82 |
DisclosureSEC source: 0001628280-26-016561 · wk-form4_1773178187.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,384 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:41 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 64,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-012360 · wk-form4_1772142065.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,817 F1 · kind: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting: 6.25% of the RSUs (rounded down to the nearest whole number) will vest every 3 months after March 8, 2026, with any remaining unvested RSUs to vest on March 8, 2030, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:05 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 3,716 | $4.38 | $16,276.08 |
DisclosureSEC source: 0001628280-25-056752 · wk-form4_1765573552.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,626 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:52 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 20,497 | $5.03 | $103,099.91 |
DisclosureSEC source: 0001628280-25-049660 · wk-form4_1762379547.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,342 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| October 31, 2025 Filed Nov 5, 2025 21:52 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 41,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-049660 · wk-form4_1762379547.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,839 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 21:04 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 3,707 | $4.00 | $14,828.00 |
DisclosureSEC source: 0001779128-25-000107 · wk-form4_1757711081.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,053 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 10, 2025 Filed Mar 23, 2026 20:02 UTC Amendment | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 3,707 | $4.00 | $14,828.00 |
DisclosureSEC source: 0001628280-26-020490 · wk-form4a_1774296144.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,570 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. F2 · balance_after: On September 12, 2025, the reporting person filed a Form 4 which reported in column 5 of Table I that, following the withholding of 3,707 shares by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units, the reporting person directly beneficially owned 100,053 shares. In fact, as reflected in this amendment, the reporting person inadvertently failed to disclose the withholding of 5,483 shares by the Issuer on September 4, 2025 to satisfy tax withholding obligations in connection with the vesting of restricted stock units. As such, the reporting person actually directly beneficially owned 94,570 shares following the withholding of 3,707 shares on September 10, 2025. As a result, the original Form 4 mistakenly overstated the reporting person's direct beneficial ownership by 5,483 shares. Read SEC document |
| September 04, 2025 Filed Mar 23, 2026 20:02 UTC Amendment | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 5,483 | $4.37 | $23,960.71 |
DisclosureSEC source: 0001628280-26-020490 · wk-form4a_1774296144.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,277 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 29, 2025 Filed Sep 4, 2025 00:23 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 11,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000094 · wk-form4_1756945389.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,760 F1 · shares: Represents a grant of fully vested Restricted Stock Units ("RSUs") effective upon the completion of the Issuer's previously announced sale of its Passenger business to Joby Aero, Inc. pursuant to that certain Equity Purchase Agreement, dated as of August 1, 2025. The RSUs will be settled in shares of the Issuer's common stock. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 22:15 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 15,426 | $3.99 | $61,549.74 |
DisclosureSEC source: 0001779128-25-000080 · wk-form4_1754432100.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,916 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 22:15 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 32,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000080 · wk-form4_1754432100.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,342 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:21 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 3,708 | $3.80 | $14,090.40 |
DisclosureSEC source: 0001779128-25-000051 · wk-form4_1749676880.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,199 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 5,208 | $3.12 | $16,248.96 |
DisclosureSEC source: 0001779128-25-000021 · wk-form4_1742243028.xml · nonDerivative · entry 3 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,907 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 26,861 | $3.12 | $83,806.32 |
DisclosureSEC source: 0001779128-25-000021 · wk-form4_1742243028.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,115 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 51,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000021 · wk-form4_1742243028.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,976 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| December 11, 2024 Filed Dec 11, 2024 22:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 4,893 | $4.72 | $23,094.96 |
DisclosureSEC source: 0001779128-24-000153 · wk-form4_1733956648.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,548 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 04, 2024 Filed Dec 4, 2024 22:48 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 5,150 | $4.36 | $22,454.00 |
DisclosureSEC source: 0001779128-24-000144 · wk-form4_1733352520.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,441 Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:48 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 5,000 | $4.55 | $22,771.50 |
DisclosureSEC source: 0001779128-24-000144 · wk-form4_1733352520.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,591 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.55 to $4.561, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 16:05 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 4,891 | $2.85 | $13,939.35 |
DisclosureSEC source: 0001779128-24-000120 · wk-form4_1726243507.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,591 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 21:22 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 4,892 | $2.94 | $14,382.48 |
DisclosureSEC source: 0001779128-24-000088 · wk-form4_1718659342.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,482 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 11,008 | $3.05 | $33,550.18 |
DisclosureSEC source: 0001779128-24-000076 · wk-form4_1718228545.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,374 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.04 to $3.0602, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 4,220 | $3.28 | $13,832.32 |
DisclosureSEC source: 0001779128-24-000054 · wk-form4_1712348783.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,382 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.175 to $3.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 21:34 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 3,985 | $2.62 | $10,459.03 |
DisclosureSEC source: 0001779128-24-000033 · wk-form4_1710538428.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,602 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 21:34 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 4,072 | $2.76 | $11,258.67 |
DisclosureSEC source: 0001779128-24-000033 · wk-form4_1710538428.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,587 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.655 to $2.875, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 22:01 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 8,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-24-000023 · wk-form4_1710280896.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,659 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. All of the RSUs will vest on April 1, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 15, 2023 Filed Dec 15, 2023 23:58 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 941 | $3.22 | $3,028.70 |
DisclosureSEC source: 0001779128-23-000137 · wk-form4_1702684693.xml · nonDerivative · entry 4 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,134 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 23:58 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 2,226 | $3.20 | $7,131.44 |
DisclosureSEC source: 0001779128-23-000137 · wk-form4_1702684693.xml · nonDerivative · entry 3 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,075 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.12 to $3.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 23:58 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 4,543 | $3.17 | $14,401.31 |
DisclosureSEC source: 0001779128-23-000137 · wk-form4_1702684693.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,301 Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 23:58 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 2,010 | $2.95 | $5,926.08 |
DisclosureSEC source: 0001779128-23-000137 · wk-form4_1702684693.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,844 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $3.0750, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 06, 2023 Filed Oct 6, 2023 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 2,009 | $2.40 | $4,817.38 |
DisclosureSEC source: 0001779128-23-000111 · wk-form4_1696634766.xml · nonDerivative · entry 3 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,854 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.335 to $2.435, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 1,556 | $2.41 | $3,753.23 |
DisclosureSEC source: 0001779128-23-000111 · wk-form4_1696634766.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,863 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.375 to $2.505, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 1,861 | $2.51 | $4,672.41 |
DisclosureSEC source: 0001779128-23-000111 · wk-form4_1696634766.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,419 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.495 to $2.575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 19:12 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 10,860 | $3.31 | $35,905.33 |
DisclosureSEC source: 0001779128-23-000096 · wf-form4_169471875904557.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,280 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.075, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 07, 2023 Filed Jul 10, 2023 22:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 1,541 | $3.82 | $5,889.39 |
DisclosureSEC source: 0001779128-23-000068 · wf-form4_168902934905904.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,130 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 22:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 1,990 | $3.88 | $7,729.96 |
DisclosureSEC source: 0001779128-23-000068 · wf-form4_168902934905904.xml · nonDerivative · entry 3 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,140 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.81 to $3.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 22:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 1,558 | $3.75 | $5,844.21 |
DisclosureSEC source: 0001779128-23-000068 · wf-form4_168902934905904.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,671 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.605 to $3.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 10, 2023 Filed Apr 11, 2023 21:09 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 2,655 | $2.83 | $7,522.94 |
DisclosureSEC source: 0001779128-23-000039 · wf-form4_168124737974567.xml · nonDerivative · entry 3 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,229 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.805 to $2.935, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 06, 2023 Filed Apr 11, 2023 21:09 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 1,348 | $2.92 | $3,929.82 |
DisclosureSEC source: 0001779128-23-000039 · wf-form4_168124737974567.xml · nonDerivative · entry 2 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,884 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 05, 2023 Filed Apr 11, 2023 21:09 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 1,750 | $2.98 | $5,211.50 |
DisclosureSEC source: 0001779128-23-000039 · wf-form4_168124737974567.xml · nonDerivative · entry 1 Cohen Amir · CIK 0001861140 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,232 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.825 to $3.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.